Rockwood Wealth Management, LLC Tyme Technologies, Inc. Transaction History

Rockwood Wealth Management, LLC

  • $909 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Jul 20, 2023
SELL
$0.0 - $0.35 $0 - $12,250
-35,000 Closed
0 $0
Q1 2022

Jul 20, 2023
BUY
$0.28 - $0.68 $2,800 - $6,800
10,000 Added 40.0%
35,000 $12.3 Million
Q4 2021

Jul 20, 2023
BUY
$0.6 - $1.04 $15,000 - $26,000
25,000 New
25,000 $15.1 Million

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Rockwood Wealth Management, LLC Portfolio

Follow Rockwood Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockwood Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rockwood Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email